Radiosurgery linked to longer survival for small cell lung cancer with brain metastases
Patients with small cell lung cancer (SCLC) that had spread to the brain lived a median of 17 months after focused stereotactic radiosurgery, compared with nine months after an advanced form of whole-brain radiation therapy, an unexpected secondary finding from the first randomized Phase III trial to compare the treatment approaches in this population.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
